Since our merger with Deepverge PLC, contractual obligations have been signed for the production of water contamination equipment worth $5 million USD (£3.6m) to meet our obligations with distributors and customers. Notably, 80% of the equipment being produced is earmarked for the Chinese market, where further assembly and localization will be carried out. These orders are expected to be delivered during the current financial year ending 31 December 2021.
Instruments from across the range of Microtox and Microtrace are being manufactured with upgrades to the software allowing optimised collection and organisation of data for real time surveillance.
Screens have been upgraded with Chinese interfaces across the range of Modern Water’s (“MW”) benchtop lab equipment.
This month over 100 of the 2019 Award-Winning Microtox benchtop and mobile instruments are completing production for immediate delivery.
40 Handheld trace metal detector PDVs have been manufactured to meet immediate obligations and a significant upgrade design is underway on a further 100 units to be produced.
Big-ticket (c$50,000 USD) online monitors from the Microtox CTM toxicity range and the Microtrace metal OVA range are being produced across two sites with 40 units scheduled for final assembly at our Shanghai, China, facilities in March.
8 MW, Microtrace OVA, units are being retrofitted with the MicrotoxPD real-time optofluidic COVID detection system for wastewater.
Upgrade to the MW reagent production line, in York, UK, being completed with the installation of a HS-2 Freeze Drying Lyophilizer from Frozen in Time. This streamlines downstream processing, automates quality control, improving volume output of the recurring revenue consumables used by most of the MW range of equipment.
Microsaic’s in-line bio-processing monitoring unit, announced in the RNS of the 15th of February, will fully automate the upstream quality control system removing all manual testing requirements.
Phase two of our manufacturing plan is being implemented to increase manufacturing capacity in China in Quarter 2, 2021 to double current capacity by year-end.
Gerard Brandon, CEO of DeepVerge plc, commented:
“Following our acquisition of MW, ongoing investment is focused on creating optimised, miniaturised and more cost-effective instruments that collect data efficiently to be processed using our AI models to deliver more detailed results faster. This enables water pollution to be detected, and when combined with external weather data, the prediction of pollution, and therefore pollution control is made possible. The software in each unit has undergone substantial upgrades to enhance the user experience of Microtox and Microtrace instruments. Automatic detection and identification of Modern Water’s reagents by our equipment ensures optimal monitoring as our tests are a regulated benchmark and, importantly for the Company, generating recurring income from these consumables.“